George Stephen

George Stephen is an accomplished pharmaceutical executive at Gilead Sciences with over 15 years of global experience leading cross-functional drug development programs, strategic planning initiatives, and portfolio management in the biotech and life sciences industries. With a proven track record in building high-performing teams, fostering inclusion, and delivering business-critical results, he brings a blend of scientific expertise and operational excellence. He holds an MBA from the University of Chicago Booth School of Business and has been featured in Science Times for his leadership in Covid-19 treatment development.